Categorization of COVID-19 severity to determine mortality risk

被引:9
|
作者
Garry, Elizabeth M. [1 ]
Weckstein, Andrew R. [1 ]
Quinto, Kenneth [2 ]
Bradley, Marie C. [3 ]
Lasky, Tamar [4 ]
Chakravarty, Aloka [4 ]
Leonard, Sandy [5 ]
Vititoe, Sarah E. [1 ]
Easthausen, Imaani J. [1 ]
Rassen, Jeremy A. [1 ]
Gatto, Nicolle M. [1 ]
机构
[1] Aetion Inc, New York, NY 10001 USA
[2] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] US FDA, Div Epidemiol, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] US FDA, Off Commissioner, Silver Spring, MD USA
[5] HealthVerity, Partnerships & RWD, Philadelphia, PA USA
关键词
administrative claims; healthcare; COVID-19; severity of illness index;
D O I
10.1002/pds.5436
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Algorithms for classification of inpatient COVID-19 severity are necessary for confounding control in studies using real-world data. Methods Using Healthverity chargemaster and claims data, we selected patients hospitalized with COVID-19 between April 2020 and February 2021, and classified them by severity at admission using an algorithm we developed based on respiratory support requirements (supplemental oxygen or non-invasive ventilation, O2/NIV, invasive mechanical ventilation, IMV, or NEITHER). To evaluate the utility of the algorithm, patients were followed from admission until death, discharge, or a 28-day maximum to report mortality risks and rates overall and by stratified by severity. Trends for heterogeneity in mortality risk and rate across severity classifications were evaluated using Cochran-Armitage and Logrank trend tests, respectively. Results Among 118 117 patients, the algorithm categorized patients in increasing severity as NEITHER (36.7%), O2/NIV (54.3%), and IMV (9.0%). Associated mortality risk (and 95% CI) was 11.8% (11.6-12.0%) overall and increased with severity [3.4% (3.2-3.5%), 11.5% (11.3-11.8%), 47.3% (46.3-48.2%); p < 0.001]. Mortality rate per 1000 person-days (and 95% CI) was 15.1 (14.9-15.4) overall and increased with severity [5.7 (5.4-6.0), 14.5 (14.2-14.9), 32.7 (31.8-33.6); p < 0.001]. Conclusion As expected, we observed a positive association between the algorithm-defined severity on admission and 28-day mortality risk and rate. Although performance remains to be validated, this provides some assurance that this algorithm may be used for confounding control or stratification in treatment effect studies.
引用
收藏
页码:721 / 728
页数:8
相关论文
共 50 条
  • [21] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    [J]. CLINICAL LABORATORY, 2021,
  • [22] Glucose variability is a marker for COVID-19 severity and mortality
    Abuhasira, Ran
    Grossman, Alon
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (06): : 856 - 862
  • [23] Association of cardiometabolic microRNAs with COVID-19 severity and mortality
    Gutmann, Clemens
    Khamina, Kseniya
    Theofilatos, Konstantinos
    Diendorfer, Andreas B.
    Burnap, Sean A.
    Nabeebaccus, Adam
    Fish, Matthew
    McPhail, Mark J. W.
    O'Gallagher, Kevin
    Schmidt, Lukas E.
    Cassel, Christian
    Auzinger, Georg
    Napoli, Salvatore
    Mujib, Salma F.
    Trovato, Francesca
    Sanderson, Barnaby
    Merrick, Blair
    Roy, Roman
    Edgeworth, Jonathan D.
    Shah, Ajay M.
    Hayday, Adrian C.
    Traby, Ludwig
    Hackl, Matthias
    Eichinger, Sabine
    Shankar-Hari, Manu
    Mayr, Manuel
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (02) : 461 - 474
  • [24] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    [J]. CLINICAL LABORATORY, 2022, 68 (02) : 291 - 297
  • [25] Biomarker Profiles Associated with COVID-19 Severity and Mortality
    Sanchez-Diez, Silvia
    Gomez-Olles, Carlos
    Cruz, Maria-Jesus
    de Homdedeu, Miquel
    Espejo, David
    Ferrer, Jaume
    Roca, Oriol
    Pacheco, Andres
    Munoz, Xavier
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (03) : 1998 - 2012
  • [26] Biomarker profiles associated with COVID-19 severity and mortality
    Sanchez-Diez, S.
    Gomez Olles, C.
    De Homdedeu, M.
    Espejo, D.
    Fabregas, C.
    Cruz, M. J.
    Munoz, X.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [27] Effects of Environmental Factors on Severity and Mortality of COVID-19
    Kifer, Domagoj
    Bugada, Dario
    Villar-Garcia, Judit
    Gudelj, Ivan
    Menni, Cristina
    Sudre, Carole
    Vuckovic, Frano
    Ugrina, Ivo
    Lorini, Luca F.
    Posso, Margarita
    Bettinelli, Silvia
    Ughi, Nicola
    Maloberti, Alessandro
    Epis, Oscar
    Giannattasio, Cristina
    Rossetti, Claudio
    Kalogjera, Livije
    Persec, Jasminka
    Ollivere, Luke
    Ollivere, Benjamin J.
    Yan, Huadong
    Cai, Ting
    Aithal, Guruprasad P.
    Steves, Claire J.
    Kantele, Anu
    Kajova, Mikael
    Vapalahti, Olli
    Sajantila, Antti
    Wojtowicz, Rafal
    Wierzba, Waldemar
    Krol, Zbigniew
    Zaczynski, Artur
    Zycinska, Katarina
    Postula, Marek
    Luksic, Ivica
    Civljak, Rok
    Markotic, Alemka
    Brachmann, Johannes
    Markl, Andreas
    Mahnkopf, Christian
    Murray, Benjamin
    Ourselin, Sebastien
    Valdes, Ana M.
    Horcajada, Juan P.
    Castells, Xavier
    Pascual, Julio
    Allegri, Massimo
    Primorac, Dragan
    Spector, Tim D.
    Barrios, Clara
    [J]. FRONTIERS IN MEDICINE, 2021, 7
  • [28] Androgens' Role in Severity and Mortality Rates of COVID-19
    Ataei, Ali
    Derakhshan, Mohammad Moein
    Razmjooie, Mohadese
    Zare, Fateme
    Amiresmaeili, Habibe
    Salehi, Negin
    Namakkoobi, Negar
    Mirhosseini, Hamid
    Karim, Bardia
    Iravani, Sima
    [J]. HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 813 - 826
  • [29] Clinical Predictors of COVID-19 Severity and Mortality: A Perspective
    Sharma, Jitender
    Rajput, Roopali
    Bhatia, Manika
    Arora, Pooja
    Sood, Vikas
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [30] Risk Factors Associated with the Severity of COVID-19
    Martono
    Fatmawati, Fitri
    Mulyanti, Sri
    [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2023, 30 (03): : 84 - 92